The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKosmos Energy Regulatory News (KOS)

Share Price Information for Kosmos Energy (KOS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 474.00
Bid: 456.00
Ask: 492.00
Change: -3.00 (-0.63%)
Spread: 36.00 (7.895%)
Open: 477.00
High: 0.00
Low: 0.00
Prev. Close: 477.00
KOS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

8 Feb 2024 07:00

RNS Number : 4137C
Kosmos Energy Limited
08 February 2024
 

Kosmos Energy Ltd (the "Company")PDMR Shareholding

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

08 February 2024

The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Stock in the Company:

PDMR

Date of transaction

No. of shares vested

No. of shares granted

No. of shares sold or withheld

Christopher J. Ball

5 February 2024

0

0

125,707

Christopher J. Ball

6 February 2024

0

0

121,915

Jason E. Doughty

5 February 2024

0

0

73,442

Jason E. Doughty

6 February 2024

0

0

71,227

Ronald W. Glass

5 February 2024

0

0

19,274

Ronald W. Glass

6 February 2024

0

0

18,693

Andrew G. Inglis

5 February 2024

0

0

182,948

Andrew G. Inglis

6 February 2024

0

0

177,430

Neal D. Shah

5 February 2024

0

0

93,267

Neal D. Shah

6 February 2024

0

0

90,454

 

The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below. The share sales above are to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Issuer's Long Term Incentive Plan (the "Plan").

This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.

 

Josh R. Marion

Assistant Secretary

CONTACT:

Investor Relations

Jamie Buckland +44 203 954 2831 jbuckland@kosmosenergy.com

Media Relations

Thomas Golembeski +1-214-445-9674 tgolembeski@kosmosenergy.com

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Christopher J. Ball

b)

Position / status

SVP and Chief Commercial Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

125,707 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

 

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

d)

Currency

USD

Price

5.4875

Volume

125,707

Total

689,817.16

e)

Aggregated information 

Price

5.4875

Volume

125,707

Total

689,817.16

f)

Date of the transactions

5 February 2024

g)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

121,915 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

 

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

d)

Currency

USD

Price

5.6581

Volume

121,915

Total

689,807.26

e)

Aggregated information 

Price

5.6581

Volume

121,915

Total

689,807.26

f)

Date of the transactions

6 February 2024

g)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Jason E. Doughty

b)

Position / status

SVP and General Counsel

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

73,442 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

 

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

d)

Currency

USD

Price

5.4875

Volume

73,442

Total

403,012.98

e)

Aggregated information 

Price

5.4875

Volume

73,442

Total

403,012.98

f)

Date of the transactions

5 February 2024

g)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

71,227 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

 

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

d)

Currency

USD

Price

5.6581

Volume

71,227

Total

403,009.49

e)

Aggregated information 

Price

5.6581

Volume

71,227

Total

403,009.49

f)

Date of the transactions

6 February 2024

g)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Ronald W. Glass

b)

Position / status

Vice President and Chief Accounting Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

19,274 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

 

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

d)

Currency

USD

Price

5.4875

Volume

19,274

Total

105,766.08

e)

Aggregated information 

Price

5.4875

Volume

19,274

Total

105,766.08

f)

Date of the transactions

5 February 2024

g)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

18,693 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

 

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

d)

Currency

USD

Price

5.6581

Volume

18,693

Total

105,766.86

e)

Aggregated information 

Price

5.6581

Volume

18,693

Total

105,766.86

f)

Date of the transactions

6 February 2024

g)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Andrew G. Inglis

b)

Position / status

Chairman and Chief Executive Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

182,948 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

 

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

d)

Currency

USD

Price

5.4875

Volume

182,948

Total

1,003,927.15

e)

Aggregated information 

Price

5.4875

Volume

182,948

Total

1,003,927.15

f)

Date of the transactions

5 February 2024

g)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

177,430 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

 

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

d)

Currency

USD

Price

5.6581

Volume

177,430

Total

1,003,916.68

e)

Aggregated information 

Price

5.6581

Volume

177,430

Total

1,003,916.68

f)

Date of the transactions

6 February 2024

g)

Place of the transaction

NYSE

 

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Neal D. Shah

b)

Position / status

Senior Vice President and Chief Financial Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

93,267 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

 

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

d)

Currency

USD

Price

5.4875

Volume

93,267

Total

511,802.66

e)

Aggregated information 

Price

5.4875

Volume

93,267

Total

511,802.66

f)

Date of the transactions

5 February 2024

g)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

90,454 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

 

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

d)

Currency

USD

Price

5.6581

Volume

90,454

Total

511,797.78

e)

Aggregated information 

Price

5.6581

Volume

90,454

Total

511,797.78

f)

Date of the transactions

6 February 2024

g)

Place of the transaction

NYSE

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSUEDWELSEIE
Date   Source Headline
26th Apr 20247:00 amRNSPublication of Proxy Statement
11th Apr 20247:00 amRNSFirst Quarter 2024 Results Date
6th Mar 20247:00 amRNSPricing of Senior Notes Offering
5th Mar 20247:00 amRNSOffering Of Convertible Senior Notes
26th Feb 20247:00 amRNSFourth Quarter 2023 Results
8th Feb 20247:00 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSDirector/PDMR Shareholding
18th Jan 20247:00 amRNSFourth Quarter 2023 Results Date
6th Nov 20237:00 amRNS3rd Quarter Results
6th Nov 20237:00 amRNSYakaar-Teranga Update
11th Oct 20237:00 amRNSOil Discovery In the U.S. Gulf of Mexico
6th Oct 20237:00 amRNSThird Quarter Results Date
7th Aug 20237:00 amRNSSecond Quarter Results
18th Jul 20237:00 amRNSRETIREMENT OF A PDMR
14th Jul 20237:00 amRNSStart Up of the Jubilee South East Project
6th Jul 20237:00 amRNSSecond Quarter Earnings Date
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
13th Jun 20237:00 amRNSReport on Payments to Govts
12th Jun 20237:17 amRNSResult of AGM
12th Jun 20237:00 amRNSDirector/PDMR Shareholding
9th May 20237:00 amRNS1st Quarter Results
2nd May 20237:00 amRNSPublication of Proxy Statement
27th Apr 20237:00 amRNSDirector/PDMR Shareholding
26th Apr 20237:00 amRNSNew Appointments To Board of Directors
19th Apr 20237:00 amRNS1st Quarter Results Date
27th Feb 20237:00 amRNSFourth Quarter And Full Year Results
3rd Feb 20237:00 amRNSDirector/PDMR Shareholding
27th Jan 20237:00 amRNSFourth Quarter 2022 Results Date
23rd Jan 20237:15 amRNSGreater Tortue Ahmeyim FPSO Sailaway
15th Nov 20224:41 pmRNSSecond Price Monitoring Extn
15th Nov 20224:36 pmRNSPrice Monitoring Extension
11th Nov 20226:00 pmRNSDirector/PDMR Shareholding
7th Nov 20227:00 amRNS3rd Quarter Results
18th Oct 20227:00 amRNS3rd Quarter Earnings Date
27th Sep 20227:00 amRNSTortue FPSO Update
19th Sep 20227:00 amRNSUpdate on Greater Tortue Ahmeyim FPSO
8th Aug 20227:00 amRNS2nd Quarter Results
21st Jul 20227:00 amRNSSecond Quarter 2022 Results Date
27th Jun 20227:00 amRNSReport on Payments to Govts
14th Jun 20227:00 amRNSDirector/PDMR Shareholding
13th Jun 20227:00 amRNSDirector/PDMR Shareholding
13th Jun 20227:00 amRNSResult of AGM
9th May 20227:00 amRNS1st Quarter Results
29th Apr 20222:10 pmRNSNotice of Annual Stockholders Meeting
26th Apr 20227:00 amRNS1st Quarter Results Date
1st Apr 20227:00 amRNSSuccessful RCF refinancing and RBL redetermination
21st Mar 20227:00 amRNSGhana Pre-emption Update
28th Feb 20227:00 amRNSFourth Quarter and Full Year 2021 Results
8th Feb 20227:00 amRNSNotice of Fourth Quarter 2021 Results
3rd Feb 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.